Rapamycin alleviates oxidative stress-induced damage in rat erythrocytes

Biochemistry and Cell Biology

Volumn 94, Issue 5, 2016, Pages 471-479

  Singh, Abhishek Kumar ^a   Singh, Sandeep ^a   Garg, Geetika ^a   Rizvi, Syed Ibrahim ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Erythrocyte; Oxidative stress; Plasma protein; Rapamycin; Reactive oxygen species

Indexed keywords

ANTIOXIDANTS; CALCIUM; CELL DEATH; CELL MEMBRANES; ENZYME ACTIVITY; OSMOSIS; OXIDATIVE STRESS; PROTEINS; RATS; REDOX REACTIONS;

ANTIOXIDANT DEFENSE; ERYTHROCYTE; FERRIC REDUCING ABILITY OF PLASMAS; PLASMA MEMBRANE REDOX SYSTEMS; PLASMA PROTEIN; RAPAMYCIN; REACTIVE OXYGEN SPECIES; STRESS-INDUCED DAMAGE;

BLOOD;

ADVANCED OXIDATION PROTEIN PRODUCT; CALCIUM ION; CARBONYL DERIVATIVE; GLUTATHIONE; HEMOGLOBIN; MERCURIC CHLORIDE; PLASMA PROTEIN; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; CALCIUM; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CELL DAMAGE; CELL MEMBRANE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG SAFETY; ERYTHROCYTE; HEMATOCRIT; IN VITRO STUDY; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; MALE; NONHUMAN; OSMOTIC FRAGILITY; OXIDATION; OXIDATIVE STRESS; RAT; THROMBOCYTE COUNT; ANIMAL; DRUG EFFECTS; METABOLISM; PATHOLOGY; WISTAR RAT;

ANIMALS; CALCIUM; ERYTHROCYTES; GLUTATHIONE; IMMUNOSUPPRESSIVE AGENTS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SIROLIMUS;

EID: 84990984022     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2016-0048     Document Type: Article

References (55)

1. Bae S.H. Sung S.H. Oh S.Y. Lim J.M. Lee S.K. Park Y.N. et al 2013. Sestrins activate Nrf2 by promoting p62-dependent autophagic degradation of Keap1 and prevent oxidative liver damage. Cell Metab. 17: 73-84. 10.1016/j.cmet.2012.12.002. 23274085.
2. Benzie I.F.F. Strain J.J. 1996. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 239: 70-76. 10.1006/abio.1996.0292. 8660627.
3. Bernhoft R.A. 2012. Mercury toxicity and treatment: a review of the literature. J. Environ. Public Health, 2012: 460508. 10.1155/2012/460508. 22235210.
4. Beutler, E. 1984. Red cell metabolism: a manual of biochemical methods. 3rd ed. Grune & Stratton, Orlando, Fla., USA.
5. Bharathi E. Jagadeesan G. 2014. Antioxidant potential of hesperidin and ellagic acid on renal toxicity induced by mercuric chloride in rats. Biomed. Prev. Nutr. 4: 131-136. 10.1016/j.bionut.2013.12.007.
6. Brandão R. Nogueira C.W. 2011. Inhibition of hepatic Î-aminolevulinate dehydratase activity induced by mercuric chloride is potentiated by N-acetylcysteine in vitro. Food Chem. Toxicol. 49: 305-308. 10.1016/j.fct.2010.10.033. 21056077.
7. Cakatay U. Aydln S. Atukeren P. Yanar K. Sitar M.E. Dalo E. Uslu E. 2013. Increased protein oxidation and loss of protein-bound sialic acid in hepatic tissues of D-galactose induced aged rats. Curr. Aging Sci. 6: 135-141. 10.2174/18746098112059990034. 23906013.
8. Calap-Quintana P. Soriano S. Llorens J.V. Al-Ramahi I. Botas J. Moltó M.D. Martínez-Sebastián M.J. 2015. TORC1 inhibition by rapamycin promotes antioxidant defences in a Drosophila model of Friedreich's ataxia. PLoS ONE, 10: e0132376. 10.1371/journal.pone.0132376. 26158631.
9. Chauhan A. Sharma U. Jagannathan N.R. Reeta K.H. Gupta Y.K. 2011. Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats. Behav. Brain Res. 225: 603-609. 10.1016/j.bbr.2011.08.035. 21903138.
10. Chong Z.Z. Maiese K. 2012. Mammalian target of rapamycin signaling in diabetic cardiovascular disease. Cardiovasc. Diabetol. 11: 45. 10.1186/1475-2840-11-45. 22545721.
11. Chong Z.Z. Shang Y.C. Zhang L. Wang S. Maiese K. 2010. Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders. Oxid. Med. Cell. Longev. 3: 374-391. 10.4161/oxim.3.6.14787. 21307646.
12. Diekmann F. Rovira J. Diaz-Ricart M. Arellano E.M. Vodenik B. Jou J.M. et al 2012. mTOR inhibition and erythropoiesis: microcytosis or anaemia? Nephrol., Dial., Transplant. 27: 537-541. 10.1093/ndt/gfr318.
13. 2+ exchanger activation. Life Sci. 89: 7-14. 10.1016/j.lfs.2011.04.017. 21600903.
14. Esterbauer H. Cheeseman K.H. 1990. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. In Methods in enzymology. Vol. 186. pp. 407-421. 10.1016/0076-6879(90)86134-H. 2233308.
15. Fang B. Xiao H. 2014. Rapamycin alleviates cisplatin-induced ototoxicity in vivo. Biochem. Biophys. Res. Commun. 448: 443-447. 10.1016/j.bbrc.2014.04.123. 24796670.
16. Fujino T. Watanabe K. Beppu M. Kikugawa K. Yasuda H. 2000. Identification of oxidized protein hydrolase of human erythrocytes as acylpeptide hydrolase. Biochim. Biophys. Acta, 1478: 102-112. 10.1016/S0167-4838(00)00004-2.
17. Gu F. Chauhan V. Chauhan A. 2015. Glutathione redox imbalance in brain disorders. Curr. Opin. Clin. Nutr. Metab. Care, 18: 89-95. 10.1097/MCO.0000000000000134.
18. Harrison D.E. Strong R. Sharp Z.D. Nelson J.F. Astle C.M. Flurkey K. et al 2009. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature, 460: 392-395. 10.1038/nature08221. 19587680.
19. Himmelfarb J. McMonagle E. 2001. Albumin is the major plasma protein target of oxidant stress in uremia. Kidney Int. 60: 358-363. 10.1046/j.1523-1755.2001.00807.x. 11422772.
20. Jiang J. Jiang J. Zuo Y. Gu Z. 2013. Rapamycin protects the mitochondria against oxidative stress and apoptosis in a rat model of Parkinson's disease. Int. J. Mol. Med. 31: 825-832. 10.3892/ijmm.2013.1280. 23426728.
21. edzierska K. Sporniak-Tutak K. Bober J. Safranow K. Olszewska M. Jakubowska K. et al 2011. Oxidative stress indices in rats under immunosuppression. Transplant. Proc. 43: 3939-3945. 10.1016/j.transproceed.2011.09.021. 22172876.
22. Kim D.-H. Sarbassov D.D. Ali S.M. King J.E. Latek R.R. Erdjument-Bromage H. et al 2002. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell, 110: 163-175. 10.1016/S0092-8674(02)00808-5. 12150925.
23. Kim S.H. Sharma R.P. 2005. Mercury alters endotoxin-induced inflammatory cytokine expression in liver: differential roles of p38 and extracellular signal-regulated mitogen-activated protein kinases. Immunopharmacol. Immunotoxicol. 27: 123-135. 10.1081/IPH-51757. 15803865.
24. Klawitter J. Bendrick-Peart J. Rudolph B. Beckey V. Klawitter J. Haschke M. et al 2009. Urine metabolites reflect time-dependent effects of cyclosporine and sirolimus on rat kidney function. Chem. Res. Toxicol. 22: 118-128. 10.1021/tx800253x. 19099400.
25. Kroemer G. Mariño G. Levine B. 2010. Autophagy and the integrated stress response. Mol. Cell, 40: 280-293. 10.1016/j.molcel.2010.09.023.
26. + channels in human erythrocyte apoptosis. Am. J. Physiol.: Cell Physiol. 285: C1553-C1560. 10.1152/ajpcell.00186.2003. 14600080.
27. Levine R.L. Garland D. Oliver C.N. Amici A. Climent I. Lenz A.G. et al 1990. Determination of carbonyl content in oxidatively modified proteins. In Methods in enzymology. Vol. 186. pp. 464-478. 10.1016/0076-6879(90)86141-H. 1978225.
28. Lipton S.A. Rosenberg P.A. 1994. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330: 613-622. 10.1056/NEJM199403033300907. 7905600.
29. Liu Y.-X. Jin L.-M. Zhou L. Xie H.-Y. Jiang G.-P. Chen H. Zheng S.-S. 2010. Sirolimus attenuates reduced-size liver ischemia-reperfusion injury but impairs liver regeneration in rats. Dig. Dis. Sci. 55: 2255-2262. 10.1007/s10620-009-1002-2. 19856103.
30. Long S.A. Rieck M. Sanda S. Bollyky J.B. Samuels P.L. Goland R. et al. for Diabetes TrialNet and the Immune Tolerance Network. 2012. Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. Diabetes, 61: 2340-2348. 10.2337/db12-0049. 22721971.
31. Lowry O.H. Rosebrough N.J. Farr A.L. Randall R.J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275. 14907713.
32. 2 formation and oxidative stress in vivo and in vitro in rat kidney mitochondria. Biochem. Pharmacol. 45: 2017-2024. 10.1016/0006-2952(93)90012-L. 8512585.
33. Ma Q. 2013. Role of Nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53: 401-426. 10.1146/annurev-pharmtox-011112-140320. 23294312.
34. Masella R. Di Benedetto R. Varì R. Filesi C. Giovannini C. 2005. Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J. Nutr. Biochem. 16: 577-586. 10.1016/j.jnutbio.2005.05.013. 16111877.
35. Mayer B. Zitta S. Greilberger J. Holzer H. Reibnegger G. Hermetter A. Oettl K. 2003. Effect of hemodialysis on the antioxidative properties of serum. Biochim. Biophys. Acta, 1638: 267-272. 10.1016/S0925-4439(03)00093-0.
36. Miller J.L. 1999. Sirolimus approved with renal transplant indication. Am. J. Health-Syst. Pharm. 56: 2177-2178. 10565691.
37. Mizushima N. Komatsu M. 2011. Autophagy: renovation of cells and tissues. Cell, 147: 728-741. 10.1016/j.cell.2011.10.026. 22078875.
38. Mohanty J.G. Nagababu E. Rifkind J.M. 2014. Red blood cell oxidative stress impairs oxygen delivery and induces red blood cell aging. Front. Physiol. 5: 84. 10.3389/fphys.2014.00084. 24616707.
39. Oettl K. Stadlbauer V. Petter F. Greilberger J. Putz-Bankuti C. Hallström S. et al 2008. Oxidative damage of albumin in advanced liver disease. Biochim. Biophys. Acta, 1782: 469-473. 10.1016/j.bbadis.2008.04.002.
40. Pandey K.B. Rizvi S.I. 2010. Markers of oxidative stress in erythrocytes and plasma during aging in humans. Oxid. Med. Cell. Longev. 3: 2-12. 10.4161/oxim.3.1.10476. 20716923.
41. Pandey K.B. Rizvi S.I. 2014. Role of resveratrol in regulation of membrane transporters and integrity of human erythrocytes. Biochem. Biophys. Res. Commun. 453: 521-526. 10.1016/j.bbrc.2014.09.117. 25285638.
42. Podbielski J. Schoenberg L. 2001. Use of sirolimus in kidney transplantation. Prog. Transplant. 11: 29-32. 10.7182/prtr.11.1.5235m177144q114j. 11357554.
43. Rizvi S.I. Jha R. Maurya P.K. 2006. Erythrocyte plasma membrane redox system in human aging. Rejuvenation Res. 9: 470-474. 10.1089/rej.2006.9.470. 17105387.
44. Rizvi S.I. Pandey K.B. Jha R. Maurya P.K. 2009. Ascorbate recycling by erythrocytes during aging in humans. Rejuvenation Res. 12: 3-6. 10.1089/rej.2008.0787. 19072252.
45. Robida-Stubbs S. Glover-Cutter K. Lamming D.W. Mizunuma M. Narasimhan S.D. Neumann-Haefelin E. et al 2012. TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO. Cell Metab. 15: 713-724. 10.1016/j.cmet.2012.04.007. 22560223.
46. Santos R.X. Correia S.C. Cardoso S. Carvalho C. Santos M.S. Moreira P.I. 2011. Effects of rapamycin and TOR on aging and memory: implications for Alzheimer's disease. J. Neurochem. 117: 927-936. 10.1111/j.1471-4159.2011.07262.x. 21447003.
47. Stadtman, E.R., and Levine, R.L. 2006. Chemical modification of proteins by reactive oxygen species. In Redox proteomics. Edited by I. Dalle-Donne, A. Scaloni, and D.A. Butterfield. John Wiley & Sons, Inc., Hoboken, N.J., USA. pp. 1-23.
48. Sullivan D.M. Wehr N.B. Fergusson M.M. Levine R.L. Finkel T. 2000. Identification of oxidant-sensitive proteins: TNF-α induces protein glutathiolation. Biochemistry (Moscow), 39: 11121-11128. 10.1021/bi0007674.
49. Tokunaga C. Yoshino K. Yonezawa K. 2004. mTOR integrates amino acid-and energy-sensing pathways. Biochem. Biophys. Res. Commun. 313: 443-446. 10.1016/j.bbrc.2003.07.019. 14684182.
50. Tunali-Akbay T. Sener G. Salvarli H. Sehirli O. Yarat A. 2007. Protective effects of Ginkgo biloba extract against mercury(II)-induced cardiovascular oxidative damage in rats. Phytother. Res. 21: 26-31. 10.1002/ptr.2007. 17072828.
51. Tuñón M.J. Sánchez-Campos S. Gutiérrez B. Culebras J.M. González-Gallego J. 2003. Effects of FK506 and rapamycin on generation of reactive oxygen species, nitric oxide production and nuclear factor kappa B activation in rat hepatocytes. Biochem. Pharmacol. 66: 439-445. 10.1016/S0006-2952(03)00288-0. 12907243.
52. Wang H. Joseph J.A. 1999. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader11Mention of a trade name, proprietary product, or specific equipment does not constitute a guarantee by the United States Department of Agriculture and does not imply its approval to the exclusion of other products that may be suitable. Free Radicals Biol. Med. 27: 612-616. 10.1016/S0891-5849(99)00107-0. 10490282.
53. Wang Y. Liu Y. Lu J. Zhang P. Wang Y. Xu Y. et al 2013. Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells. Biochem. Biophys. Res. Commun. 434: 352-356. 10.1016/j.bbrc.2013.03.077. 23558291.
54. Witko-Sarsat V. Friedlander M. Capeillère-Blandin C. Nguyen-Khoa T. Nguyen A.T. Zingraff J. et al 1996. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49: 1304-1313. 10.1038/ki.1996.186. 8731095.
55. Wood B.L. Gibson D.F. Tait J.F. 1996. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood, 88: 1873-1880. 8781447.